NOMAD POWER SOLUTIONS, INC. Adjustments to Additional Paid in Capital, Other
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Adjustments to Additional Paid in Capital, Other of -$17.88 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2026-08-14
- NOMAD POWER SOLUTIONS, INC. adjustments to additional paid in capital, other for the quarter ending 2026-03-31 was -$17.88K.
- NOMAD POWER SOLUTIONS, INC. adjustments to additional paid in capital, other for the quarter ending 2012-12-31 was $0.00.
- NOMAD POWER SOLUTIONS, INC. adjustments to additional paid in capital, other for the quarter ending 2011-12-31 was $0.00.
- NOMAD POWER SOLUTIONS, INC. adjustments to additional paid in capital, other for fiscal 2012 was $1.14M, a 470.26% increase from fiscal 2011.
- NOMAD POWER SOLUTIONS, INC. adjustments to additional paid in capital, other for fiscal 2011 was $199.84K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|
| 2026-03-31 | -$17.88K 10-Q · filed 2026-08-14 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $1.14M 10-K · filed 2014-03-21 | |
| 2012-09-30 | $1.14M 10-Q · filed 2012-11-13 | ||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $199.84K 10-K · filed 2014-03-21 | |
| 2011-09-30 | $199.84K 10-Q · filed 2011-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |